(HealthDay)—More than 9,000 people in the United States may have been infected with the new coronavirus as of March 1— a figure much higher than reported, researchers say.
Mar 9, 2020
0
22
The millions of people who have chronic sinusitis deal not only with stuffy noses and headaches, they also commonly struggle to focus, and experience depression and other symptoms that implicate the brain's involvement in ...
Apr 8, 2021
0
45
Most patients hospitalized with COVID-19 (coronavirus) pneumonia experienced improvement after receiving a Food and Drug Administration-approved drug normally given for rheumatoid arthritis, according to an observational ...
Jul 15, 2020
1
186
(HealthDay)—One in five U.S. adults may be tolerating gastrointestinal (GI) symptoms and not seeking care, according to a survey released by the American Gastroenterological Association (AGA).
Nov 15, 2021
0
3
In a small room at Lucile Packard Children’s Hospital, Megan and Ricky Gonzales each held one hand of their daughter Sophia, comforting her as she recovered from a Nov. 8 liver transplant. Near Sophia’s crib, her ...
Jan 9, 2012
0
0
With nearly 5 million confirmed cases globally and more than 300,000 deaths from COVID-19, much remains unknown about SARS-CoV-2, the virus that causes the disease. Two critical questions are whether vaccines will prevent ...
May 20, 2020
0
920
A large team of researchers affiliated with a host of institutions in the U.S., France and Spain has found that the drug plitidepsin worked better at treating COVID-19 than did remdesivir in a lab setting. In their paper ...
Penn Medicine researchers have found that middle-aged individuals—those born in the late 1960s and the 1970s—may be in a perpetual state of H3N2 influenza virus susceptibility because their antibodies bind to H3N2 viruses ...
Sep 11, 2020
1
326
With Aotearoa New Zealand's move into phase 3 of its response to the omicron outbreak, new definitions and protocols for testing and isolation will mean new ways of measuring the impact of COVID-19.
Feb 25, 2022
0
19
An antidepressant medication is being tested as a potential treatment for COVID-19 after University of Virginia School of Medicine researchers determined it may prevent dangerous overreactions by the immune system.
May 12, 2020
0
2
